Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Blood Cells, Molecules & Diseases
|
June 26, 2007
Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO
Robert Hines, Anita Boyapati, Dong-Er Zhang
Biochemical and Biophysical Research Communications
|
July 5, 2011
SERPINB13 is a novel RUNX1 target gene
Anita Boyapati, Bing Ren, Dong-Er Zhang
Acta Haematologica
|
December 4, 2003
p53 alterations in myeloid leukemia
Anita Boyapati, Eiki Kanbe, Dong-Er Zhang
Virology
|
November 1, 2003
SV40 17KT antigen complements dnaj mutations in large T antigen to restore transformation of primary human fibroblasts
Anita Boyapati, Marlena Wilson, Jing Yu, et al.
Molecular Cancer Research : MCR
|
March 4, 2010
3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway
Zhuomei Lu, Mary Ann Cox-Hipkin, William T Windsor, et al.
Arthritis Research & Therapy
|
October 21, 2020
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab
Vibeke Strand, Susan H Boklage, Toshio Kimura, et al.
Blood
|
May 31, 2008
t(8;21)(q22;q22) Fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
Akiko J Okumura, Luke F Peterson, Fumihiko Okumura, et al.
Ejhaem
|
November 10, 2025
Radiologic Pseudoprogression Associated With a Positive Response in a Patient With Multiple Myeloma Treated With a BCMA×CD3 Bispecific Antibody: A Case Report
Abdullah M Khan, Glenn S Kroog, Tito Roccia, et al.
Journal of Lipid Research
|
May 25, 2024
Effect of IL-6R blockade on plasma lipids and clinical outcomes among hospitalized patients with COVID-19 infection
Kusha Mohammadi, Mark W Sleeman, Anita Boyapati, et al.
Arthritis Research & Therapy
|
October 8, 2016
Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
Anita Boyapati, Jérôme Msihid, Stefano Fiore, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Blood Cells, Molecules & Diseases
|
June 26, 2007
Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO
Robert Hines, Anita Boyapati, Dong-Er Zhang
Biochemical and Biophysical Research Communications
|
July 5, 2011
SERPINB13 is a novel RUNX1 target gene
Anita Boyapati, Bing Ren, Dong-Er Zhang
Acta Haematologica
|
December 4, 2003
p53 alterations in myeloid leukemia
Anita Boyapati, Eiki Kanbe, Dong-Er Zhang
Virology
|
November 1, 2003
SV40 17KT antigen complements dnaj mutations in large T antigen to restore transformation of primary human fibroblasts
Anita Boyapati, Marlena Wilson, Jing Yu, et al.
Molecular Cancer Research : MCR
|
March 4, 2010
3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway
Zhuomei Lu, Mary Ann Cox-Hipkin, William T Windsor, et al.
Arthritis Research & Therapy
|
October 21, 2020
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab
Vibeke Strand, Susan H Boklage, Toshio Kimura, et al.
Blood
|
May 31, 2008
t(8;21)(q22;q22) Fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
Akiko J Okumura, Luke F Peterson, Fumihiko Okumura, et al.
Ejhaem
|
November 10, 2025
Radiologic Pseudoprogression Associated With a Positive Response in a Patient With Multiple Myeloma Treated With a BCMA×CD3 Bispecific Antibody: A Case Report
Abdullah M Khan, Glenn S Kroog, Tito Roccia, et al.
Journal of Lipid Research
|
May 25, 2024
Effect of IL-6R blockade on plasma lipids and clinical outcomes among hospitalized patients with COVID-19 infection
Kusha Mohammadi, Mark W Sleeman, Anita Boyapati, et al.
Arthritis Research & Therapy
|
October 8, 2016
Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
Anita Boyapati, Jérôme Msihid, Stefano Fiore, et al.
Page
of 4